|
× |
|
Why Do Some Patients With Schizophrenia Want to Be Engaged in Medical Decision Making and Others Do Not? PDF |
$40.00 |
|
$40.00 |
|
× |
|
Subacute Sclerosing Panencephalitis Masquerading as Schizophrenia: An Example of Diagnostic Overshadowing in Neuropsychiatry PDF |
$40.00 |
|
$40.00 |
|
× |
|
Cigarette Use and Cannabis Use Disorder Onset, Persistence, and Relapse: Longitudinal Data From a Representative Sample of US Adults PDF |
$40.00 |
|
$40.00 |
|
× |
|
Successful Management of Difficult-to-Treat Aggression With Low-Dose Propranolol in a Patient With Intellectual Disability: A Case Report PDF |
$40.00 |
|
$40.00 |
|
× |
|
I Use "Wax" Because It Makes Me Calmer, But Now I Am Seeing 3D Images PDF |
$40.00 |
|
$40.00 |
|
× |
|
Clinical and Polysomnographic Features of Sleep-Related Eating Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Antidepressant Use and Risk of Recurrent Stroke: A Population-Based Nested Case-Control Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Recombinant Human Erythropoietin to Target Cognitive Dysfunction in Bipolar Disorder: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Is Flunarizine a Long-Acting Oral Atypical Antipsychotic? A Randomized Clinical Trial Versus Haloperidol for the Treatment of Schizophrenia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Open-Label Extension Phase and Both Phases of a Randomized Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Psychosis in Mania: Specificity of Its Role in Severity and Treatment Response PDF |
$40.00 |
|
$40.00 |
|
× |
|
Citalopram Treatment of Compulsive Shopping: An Open-Label Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Adjunctive Modafinil at Initiation of Treatment With a Selective Serotonin Reuptake Inhibitor Enhances the Degree and Onset of Therapeutic Effects in Patients With Major Depressive Disorder and Fatigue PDF |
$40.00 |
|
$40.00 |
|
× |
|
Screening for DSM-5 Other Specified Feeding or Eating Disorder in a Weight-Loss Treatment-Seeking Obese Sample PDF |
$40.00 |
|
$40.00 |
|
× |
|
Can Long-Term Treatment With Antidepressant Drugs Worsen the Course of Depression? PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy of Antipsychotic Drugs Against Hostility in the European First-Episode Schizophrenia Trial (EUFEST) PDF |
$40.00 |
|
$40.00 |
|
× |
|
Patient-Level Predictors and Clinical Correlates of Duration of Untreated Psychosis Among Hospitalized First-Episode Patients PDF |
$40.00 |
|
$40.00 |
|
× |
|
Treatment of Restless Legs Syndrome With Tramadol: An Open Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Olanzapine-Associated Leukopenia and Thrombocytopenia Managed With Lithium in a Patient Who Developed Leukopenia With Clozapine in the Past: A Case Report PDF |
$40.00 |
|
$40.00 |
|
× |
|
Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Intended and Unintended Consequences of the Gabapentin Off-Label Marketing Lawsuit Among Patients With Bipolar Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Subjective Medication Satisfaction With Antipsychotic Polypharmacy in a Naturalistic Inpatient and Outpatient Sample PDF |
$40.00 |
|
$40.00 |
|
× |
|
Paroxetine and Fluoxetine Effects On Mood and Cognitive Functions in Depressed Nondemented Elderly Patients PDF |
$40.00 |
|
$40.00 |
|
× |
|
Health-Related Quality of Life Across the Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Efficacy of Omega-3 Supplementation for Major Depression: A Randomized Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Treatment of Postpartum Depression, Part 2: A Critical Review of Nonbiological Interventions PDF |
$40.00 |
|
$40.00 |
|
|